Shanghai 10th People's Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Type 2 diabetes1 trial

Phase

• Phase 43 trials
• Phase 11 trial
• Phase 1/21 trial

Status

• Recruiting3 trials
• Not yet recruiting2 trials

Lead sponsor

• Peking University First Hospital1 trial
• Shandong Provincial Hospital1 trial
• Shanghai 6th People's Hospital1 trial
• Shanghai Jiao Tong University School of Medicine1 trial
• Xintian Pharmaceutical1 trial

Running trials

• Not yet recruiting

  A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

  NCT07632235· Phase 1/2· Shanghai 6th People's Hospital· Source

  Contact: Jun Li

• Recruiting

  Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules

  NCT06423235· Phase 4· Xintian Pharmaceutical· Source

  Contact: Shen Qu (sub-investigator)

• Not yet recruiting

  Henagliflozin's Impact on Prediabetes Remission

  NCT06448130· Phase 4· Shandong Provincial Hospital· Source

  Contact: Xiude Fan, MD&PhD

• Recruiting

  Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

  NCT04532606· Phase 4· Peking University First Hospital· Source

  Contact: Xuan Zhao, MD

• Recruiting

  A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer

  NCT02889666· Phase 1· Shanghai Jiao Tong University School of Medicine· Source

  Contact: Da Fu, Ph.D

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bladder cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Type 2 diabetes1 recruiting